<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-95141</identifier>
<setSpec>0210-5691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Thrombolysis in acute ischemic stroke in basic hospitals. Four cases reports</dc:title>
<dc:description xml:lang="en">Thrombolytic drugs have been used in recent years as an effective therapeutic option in ischemic stroke. There are several experiences with the administration of thrombolytic therapy in basic and rural hospitals. We are describing our experience with four cases in which this treatment was used in our basic hospital during the last three years. We used a strict protocol described in the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA stroke study. No intracranial hemorrhage or protocol violations were detected. We conclude that this protocol has allowed us to offer safe treatment to our ischemic stroke patients (AU)</dc:description>
<dc:creator>Varela, A</dc:creator>
<dc:creator>Zaheri, M</dc:creator>
<dc:creator>Rojas, P. de</dc:creator>
<dc:creator>Vázquez, A</dc:creator>
<dc:creator>Vegas, R</dc:creator>
<dc:creator>Cabello, B</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tratamiento trombolítico se ha consolidado en los últimos años como una opción terapéutica efectiva en el ictus isquémico. Existen variadas experiencias en la administración de tratamiento trombolítico en hospitales básicos y rurales. Describimos cuatro casos en los que hemos realizado tratamiento trombolítico en un hospital básico. Hemos utilizado un protocolo estricto de administración basado en el protocolo descrito en el National Institute of Neurological Disorders and Stroke (NINDS) rt-PA stroke study. No hemos detectado ni complicaciones hemorrágicas ni violaciones del protocolo. Concluimos que este protocolo nos ha permitido ofrecer un tratamiento seguro a nuestros pacientes con ictus isquémico (AU)</dc:description>
<dc:source>Med. intensiva (Madr., Ed. impr.);34(6): 428-430, ago.-sept. 2010.</dc:source>
<dc:identifier>ibc-95141</dc:identifier>
<dc:title xml:lang="es">Trombolisis en el ictus isquémico agudo en hospitales básicos. A propósito de cuatro casos</dc:title>
<dc:subject>^d2585^s22067</dc:subject>
<dc:subject>^d27977^s22048</dc:subject>
<dc:subject>^d19291^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d34247^s22067</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d24892^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201009</dc:date>
</metadata>
</record>
</ibecs-document>
